Low serum levels of bone turnover markers are associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes mellitus.

Tytuł:: Low serum levels of bone turnover markers are associated with the presence and severity of diabetic retinopathy in patients with type 2 diabetes mellitus.
Autorzy:: An Y; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Liu S; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Wang W; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Dong H; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Zhao W; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Ke J; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Zhao D; Center for Endocrine Metabolism and Immune Diseases, Beijing Luhe Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Diabetes Research and Care, Beijing, China.
Źródło:: Journal of diabetes [J Diabetes] 2021 Feb; Vol. 13 (2), pp. 111-123. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Original Publication: Richmond, Vic. : Blackwell Publishing Asia, 2009-
MeSH Terms:: Bone Remodeling/*physiology
Collagen Type I/*blood
Diabetes Mellitus, Type 2/*blood
Diabetic Retinopathy/*diagnosis
Osteocalcin/*blood
Peptide Fragments/*blood
Peptides/*blood
Procollagen/*blood
Biomarkers/blood ; Cross-Sectional Studies ; Diabetic Retinopathy/blood ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index
References:: Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. Jama. 2007;298:902-916.
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124-136.
Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-564.
Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8:010803.
Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009;116:461-467.
Siris ES, Adler R, Bilezikian J, et al. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int. 2014;25:1439-1443.
Jia P, Bao L, Chen H, et al. Risk of low-energy fracture in type 2 diabetes patients: a meta-analysis of observational studies. Osteoporos Int. 2017;28:3113-3121.
Ni Y, Fan D. Diabetes mellitus is a risk factor for low bone mass-related fractures: a meta-analysis of cohort studies. Medicine (Baltimore). 2017;96:e8811.
Koh WP, Wang R, Ang LW, Heng D, Yuan JM, Yu MC. Diabetes and risk of hip fracture in the Singapore Chinese Health Study. Diabetes Care. 2010;33:1766-1770.
Tebe C, Martinez-Laguna D, Moreno V, et al. Differential mortality and the excess rates of hip fracture associated with type 2 diabetes: accounting for competing risks in fracture prediction matters. J Bone Miner Res. 2018;33:1417-1421.
Jiajue R, Qi X, Jiang Y, et al. Incident fracture risk in type 2 diabetic postmenopausal women in mainland China: Peking Vertebral Fracture Study. Calcif Tissue Int. 2019;105:466-475.
van Daele PL, Stolk RP, Burger H, et al. Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam study. Ann Intern Med. 1995;122:409-414.
Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care. 1999;22:1196-1200.
Ivers RQ, Cumming RG, Mitchell P, Peduto AJ, Blue Mountains Eye Study. Diabetes and risk of fracture: the Blue Mountains Eye Study. Diabetes Care. 2001;24:1198-1203.
Oz SG, Guven GS, Kilicarslan A, Calik N, Beyazit Y, Sozen T. Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus. J Natl Med Assoc. 2006;98:1598-1604.
Schwartz AV, Vittinghoff E, Bauer DC, et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA. 2011;305:2184-2192.
Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T. Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res. 2009;24:702-709.
Chen C, Chen Q, Nie B, et al. Trends in bone mineral density, osteoporosis, and osteopenia among U.S. adults with prediabetes, 2005-2014. Diabetes Care. 2020;43:1008-1015.
Burghardt AJ, Issever AS, Schwartz AV, et al. High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab. 2010;95:5045-5055.
Ho-Pham LT, Chau PMN, Do AT, Nguyen HC, Nguyen TV. Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporos Int. 2018;29:2059-2067.
Shanbhogue VV, Hansen S, Frost M, et al. Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease. Eur J Endocrinol. 2016;174:115-124.
Zhukouskaya VV, Eller-Vainicher C, Vadzianava VV, et al. Prevalence of morphometric vertebral fractures in patients with type 1 diabetes. Diabetes Care. 2013;36:1635-1640.
Lim Y, Chun S, Lee JH, et al. Association of bone mineral density and diabetic retinopathy in diabetic subjects: the 2008-2011 Korea National Health and Nutrition Examination Survey. Osteoporos Int. 2016;27:2249-2257.
Naylor K, Eastell R. Bone turnover markers: use in osteoporosis. Nat Rev Rheumatol. 2012;8:379-389.
Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11:337-349.
Lofman O, Magnusson P, Toss G, Larsson L. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study. Clin Chim Acta. 2005;356:67-75.
Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Mod Rheumatol. 2011;21:608-620.
Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab. 1997;82:719-724.
Dai Z, Wang R, Ang LW, Yuan JM, Koh WP. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population. Bone. 2016;83:171-177.
Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus - a systematic review. Bone. 2016;82:69-78.
Hygum K, Starup-Linde J, Harslof T, Vestergaard P, Langdahl BL. Mechanisms in endocrinology: diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. Eur J Endocrinol. 2017;176:R137-R157.
Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019;8:R55-R70.
Maghbooli Z, Shabani P, Gorgani-Firuzjaee S, Hossein-Nezhad A. The association between bone turnover markers and microvascular complications of type 2 diabetes. J Diabetes Metab Disord. 2016;15:51.
Zhang X, Yang J, Zhong Y, et al. Association of bone metabolic markers with diabetic retinopathy and diabetic macular edema in elderly Chinese individuals with type 2 diabetes mellitus. Am J Med Sci. 2017;354:355-361.
Zhang Y, Wang W, Ning G. Metabolic Management Center: an innovation project for the management of metabolic diseases and complications in China. J Diabetes. 2019;11:11-13.
World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO Department of Noncommunicable Disease Surveillance; 1999:1-59.
Lanzetta P, Sarao V, Scanlon PH, et al. Fundamental principles of an effective diabetic retinopathy screening program. Acta Diabetol. 2020;57(7):785-798.
Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786-806.
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
Leite Duarte ME, da Silva RD. Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID). Rev Hosp Clin Fac Med Sao Paulo. 1996;51:7-11.
Manavalan JS, Cremers S, Dempster DW, et al. Circulating osteogenic precursor cells in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2012;97:3240-3250.
Khan MP, Singh AK, Joharapurkar AA, et al. Pathophysiological mechanism of bone loss in type 2 diabetes involves inverse regulation of osteoblast function by PGC-1alpha and skeletal muscle atrogenes: AdipoR1 as a potential target for reversing diabetes-induced osteopenia. Diabetes. 2015;64:2609-2623.
Napoli N, Strollo R, Paladini A, Briganti SI, Pozzilli P, Epstein S. The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol. 2014;2014:690783.
Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-469.
Liu JM, Rosen CJ, Ducy P, Kousteni S, Karsenty G. Regulation of glucose handling by the skeleton: insights from mouse and human studies. Diabetes. 2016;65:3225-3232.
Ogata M, Ide R, Takizawa M, et al. Association between basal metabolic function and bone metabolism in postmenopausal women with type 2 diabetes. Nutrition. 2015;31:1394-1401.
Wang L, Li T, Liu J, et al. Association between glycosylated hemoglobin A1c and bone biochemical markers in type 2 diabetic postmenopausal women: a cross-sectional study. BMC Endocr Disord. 2019;19:31.
Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009;94:827-832.
Yeap BB, Alfonso H, Chubb SA, et al. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab. 2015;100:63-71.
Massera D, Biggs ML, Walker MD, et al. Biochemical markers of bone turnover and risk of incident diabetes in older women: the cardiovascular health study. Diabetes Care. 2018;41:1901-1908.
Xuan Y, Sun LH, Liu DM, et al. Positive association between serum levels of bone resorption marker CTX and HbA1c in women with normal glucose tolerance. J Clin Endocrinol Metab. 2015;100:274-281.
Liu TT, Liu DM, Xuan Y, et al. The association between the baseline bone resorption marker CTX and incident dysglycemia after 4 years. Bone Res. 2017;5:17020.
Contributed Indexing:: Keywords: 2型糖尿病; bone turnover markers; diabetic retinopathy; type 2 diabetes mellitus; 糖尿病视网膜病变; 骨转化标志物
Local Abstract: [Publisher, Chinese] 背景: 越来越多的证据表明2型糖尿病及其微血管并发症与骨折风险增加相关。在这项研究中，我们旨在评估2型糖尿病患者中骨转换标志物的血清水平与糖尿病视网膜病变(diabetic retinopathy,DR)的存在和/或其严重程度的相关性。方法: 在这项横断面研究中，我们共纳入285例2型糖尿病患者，包括168例无DR的2型糖尿病患者和117例合并DR的2型糖尿病患者。此外，DR组进一步分为轻度病变患者和重度病变患者。所有参与者均测定生化参数和骨转换标志物。结果: 本研究发现，与无DR相比，DR患者的骨形成标记物1型原胶原N-端前肽(P1NP)和骨吸收标志物1型胶原β交联C端肽(β-CTX)的血清浓度均降低，进一步的多元线性回归模型结果显示，校正多种混杂因素后，该差异仍显著存在(P<0.05)。此外，随着DR的严重程度加重，骨钙素与β-CTX的血清浓度进一步下降。多因素逻辑回归分析显示，低血清水平的P1NP和β-CTX可能与高更的DR发病率相关，而β-CTX与DR的严重程度相关。结论: 本研究结果提示DR的发生发展可能参与了2型糖尿病引起的骨形成与骨吸收缺陷，或者相反，但尚需进一步研究验证相关性并明确机制。.
Substance Nomenclature:: 0 (Biomarkers)
0 (Collagen Type I)
0 (Peptide Fragments)
0 (Peptides)
0 (Procollagen)
0 (collagen type I trimeric cross-linked peptide)
0 (procollagen Type I N-terminal peptide)
104982-03-8 (Osteocalcin)
Entry Date(s):: Date Created: 20200717 Date Completed: 20210121 Latest Revision: 20210121
Update Code:: 20240105
DOI:: 10.1111/1753-0407.13089
PMID:: 32671958
: Czasopismo naukowe

Pełny tekst

Background: Accumulating evidence demonstrates an association of type 2 diabetes mellitus (T2DM) and its microvascular complications with increased fracture risk. In this study, we aimed to evaluate the relationships between serum concentrations of bone turnover markers and the presence and/or severity of diabetic retinopathy (DR) among patients with T2DM.
Methods: A total of 285 patients with T2DM comprising 168 patients without DR and 117 patients with DR were enrolled in the cross-sectional study. In the latter group, patients were further divided into patients of mild and severe DR stages. The biochemical parameters and bone turnover markers were determined in all participants.
Results: This study found that serum levels of procollagen type 1 N-terminal propeptide (P1NP), a bone formation marker, and the bone resorption marker serum β-cross-linked C-telopeptide of type I collagen (β-CTX) were more decreased in diabetic patients with DR than in those without DR, with differences remaining significant (P < .05) in multivariate linear regression models after adjustments for multiple confounding factors. Osteocalcin and β-CTX levels were further reduced along with the severity of DR among participants with DR. Moreover, multivariate logistic regression analysis revealed that lower serum levels of P1NP and β-CTX were associated with higher odds for the presence of DR, while β-CTX was associated with the severity of DR.
Conclusion: Our results suggest that the development of DR might be involved in the progression of T2DM-induced deficits in bone formation and resorption or vice versa. Follow-up studies and further research are necessary to validate the associations and elucidate the underlying mechanisms.
(© 2020 Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley & Sons Australia, Ltd.)

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja